Our findings confirm the oncogenic role of MYC in CML pathogenesis, suggesting a causal relationship with the increased BCR/ABL1 levels observed during CML progression. The gene discussed is MYC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.